vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and ServisFirst Bancshares, Inc. (SFBS). Click either name above to swap in a different company.
ServisFirst Bancshares, Inc. is the larger business by last-quarter revenue ($159.0M vs $151.7M, roughly 1.0× Nutex Health, Inc.). ServisFirst Bancshares, Inc. runs the higher net margin — 52.2% vs 7.8%, a 44.4% gap on every dollar of revenue. Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 17.7%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
ServisFirst Bancshares, Inc. is a U.S.-based bank holding company operating full-service banking locations primarily across the Southeastern United States. It offers a full suite of commercial banking, consumer banking, wealth management, and mortgage lending services to small and medium-sized businesses, professional clients, and individual consumers.
NUTX vs SFBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $159.0M |
| Net Profit | $11.8M | $83.0M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | — |
| Net Margin | 7.8% | 52.2% |
| Revenue YoY | -41.1% | — |
| Net Profit YoY | -80.8% | 31.2% |
| EPS (diluted) | $2.34 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $159.0M | ||
| Q4 25 | $151.7M | $162.2M | ||
| Q3 25 | $267.8M | $136.3M | ||
| Q2 25 | $244.0M | $132.1M | ||
| Q1 25 | $211.8M | $131.8M | ||
| Q4 24 | $257.6M | $131.9M | ||
| Q3 24 | $78.8M | $123.7M | ||
| Q2 24 | $76.1M | $114.8M |
| Q1 26 | — | $83.0M | ||
| Q4 25 | $11.8M | $86.4M | ||
| Q3 25 | $55.4M | $65.6M | ||
| Q2 25 | $-17.7M | $61.4M | ||
| Q1 25 | $21.2M | $63.2M | ||
| Q4 24 | $61.6M | $65.2M | ||
| Q3 24 | $-8.8M | $59.9M | ||
| Q2 24 | $-364.0K | $52.1M |
| Q1 26 | — | — | ||
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 20.4% | 66.3% | ||
| Q3 25 | 48.7% | 57.8% | ||
| Q2 25 | 13.8% | 58.0% | ||
| Q1 25 | 38.1% | 60.0% | ||
| Q4 24 | 44.4% | 60.2% | ||
| Q3 24 | 12.3% | 58.5% | ||
| Q2 24 | 7.0% | 58.0% |
| Q1 26 | — | 52.2% | ||
| Q4 25 | 7.8% | 59.0% | ||
| Q3 25 | 20.7% | 48.1% | ||
| Q2 25 | -7.3% | 46.5% | ||
| Q1 25 | 10.0% | 48.0% | ||
| Q4 24 | 23.9% | 52.9% | ||
| Q3 24 | -11.2% | 48.4% | ||
| Q2 24 | -0.5% | 45.4% |
| Q1 26 | — | $1.52 | ||
| Q4 25 | $2.34 | $1.58 | ||
| Q3 25 | $7.76 | $1.20 | ||
| Q2 25 | $-2.95 | $1.12 | ||
| Q1 25 | $3.33 | $1.16 | ||
| Q4 24 | $11.56 | $1.19 | ||
| Q3 24 | $-1.72 | $1.10 | ||
| Q2 24 | $-0.07 | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $1.8B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $1.9B |
| Total Assets | $918.5M | $18.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.8B | ||
| Q4 25 | $185.6M | — | ||
| Q3 25 | $166.0M | — | ||
| Q2 25 | $96.7M | — | ||
| Q1 25 | $84.7M | — | ||
| Q4 24 | $40.6M | — | ||
| Q3 24 | $46.9M | — | ||
| Q2 24 | $40.8M | — |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $329.4M | $1.8B | ||
| Q3 25 | $317.2M | $1.8B | ||
| Q2 25 | $235.3M | $1.7B | ||
| Q1 25 | $176.9M | $1.7B | ||
| Q4 24 | $132.4M | $1.6B | ||
| Q3 24 | $60.4M | $1.6B | ||
| Q2 24 | $62.7M | $1.5B |
| Q1 26 | — | $18.2B | ||
| Q4 25 | $918.5M | $17.7B | ||
| Q3 25 | $964.5M | $17.6B | ||
| Q2 25 | $841.0M | $17.4B | ||
| Q1 25 | $761.9M | $18.6B | ||
| Q4 24 | $655.3M | $17.4B | ||
| Q3 24 | $438.5M | $16.4B | ||
| Q2 24 | $422.4M | $16.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | — |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $70.4M | $355.2M | ||
| Q3 25 | $99.5M | $140.9M | ||
| Q2 25 | $27.3M | $67.6M | ||
| Q1 25 | $51.0M | $48.0M | ||
| Q4 24 | $54.0K | $252.9M | ||
| Q3 24 | $6.8M | $84.0M | ||
| Q2 24 | $13.3M | $48.3M |
| Q1 26 | — | — | ||
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $12.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 5.95× | 4.11× | ||
| Q3 25 | 1.80× | 2.15× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | 2.40× | 0.76× | ||
| Q4 24 | 0.00× | 3.88× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
SFBS
| Net Interest Income | $148.1M | 93% |
| Noninterest Income | $10.8M | 7% |
